MNKD · Mannkind Corp
Market Cap
$1.31B
Shares
321.54M
MNKD metrics
73 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$4.06
Market cap
$1.31B
Price action
19 metricsPrice change (1W)
+2.8%
Price change (30D)
+3.3%
Price change (3M)
+19.4%
Price change (6M)
+55.6%
Price change (YTD)
-28.4%
Price change (1Y)
-24.0%
Trailing year
Price change (5Y)
-14.0%
52-week high
$6.21
52-week low
$2.28
Change from 52-week high
-34.6%
Change from 52-week low
+78.1%
Annualized volatility
68.2%
Beta
1.1
RSI (14D)
51.6
Price vs SMA 50
+0.4%
Price vs SMA 200
-2.3%
Avg volume (3M)
4.49M
Relative volume
0.6
Average dollar volume
$17.96M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
321.54M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.3×
reciprocal yield 30.2%
P / book
—
FCF yield
-1.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.3%
Historical valuation
8 metricsP / E historical average (3Y)
82.2×
reciprocal yield 1.2%
P / E historical average (5Y)
82.2×
reciprocal yield 1.2%
EV / revenue historical average (3Y)
5.2×
reciprocal yield 19.3%
EV / revenue historical average (5Y)
8.5×
reciprocal yield 11.8%
EV / EBIT historical average (3Y)
52.3×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
52.3×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
28.9×
reciprocal yield 3.5%
EV / EBITDA historical average (5Y)
28.9×
reciprocal yield 3.5%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
89.8%
Operating margin
2.3%
Trailing 12 months
Net margin
-11.1%
Gross profit (TTM)
—
Operating profit (TTM)
$9.19M
Net income (TTM)
−$43.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
-4.6%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+42.9%
Year over year
Net income growth YoY
-2,949.1%
Revenue (TTM)
$393.63M
Trailing 12 months
EPS growth YoY
-80.0%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+51.8%
Revenue CAGR (5Y)
+39.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-6.0%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$30.06M
Free cash flow (TTM)
−$18.14M
Quick ratio
1.4
Interest coverage
0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$52.93M
Total assets
$732.30M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$8.05M
Capital expenditures (TTM)
$10.08M
R&D (TTM)
$76.88M
SG&A (TTM)
$199.89M
Stock compensation (TTM)
$27.97M
R&D / revenue
19.5%
Stock compensation / revenue
7.1%
Ownership (13F)
3 metrics13F filers
259
13F filer change QoQ
+5
Institutional ownership
57.4%
Short interest
3 metricsShort interest
8.9%
Latest settlement · 5.6 days to cover
Days to cover
5.6d
Short-squeeze score
73 / 100
Insider activity
2 metricsNet insider buying (90D)
−$469,278
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
899460
CUSIP
56400P706
13F (30d)
160 filings
160 filers
Visit website
Investor relations